Regulatory complexity
HIPAA, FDA, state rules. Sales books demos before compliance signs off. One miss can kill a deal or push a launch into next quarter.
Healthcare growth strategy
Fix the handoffs slowing healthcare revenue.
At $10M-$100M, healthcare deals die in the gaps between product, sales, and compliance. I work inside that gap. A Growth-Stage Healthcare Marketplace grew more than 60% after we put marketing, product, sales, ops, and credentialing on one weekly rhythm. HIPAA and FDA do not get a free pass. They get a checkpoint with an owner.
Prefer a call? Book a Revenue Strategy Call
Where healthcare deals stall
- 1. DemandQualified interestMarketing and referrals open the door.
- 2. ValidationClinical and compliance reviewDeals slow when proof, risk, and ownership are fuzzy.
- 3. ProcurementBudget and stakeholder approvalCommittees and budget windows. No owner, no progress.
- 4. IntegrationWorkflow and interoperabilityCustom EHR and claims work eats the roadmap.
- 5. RevenueOrder, adoption, renewalMoney lands only if every prior handoff had an owner.
What is healthcare growth strategy for $10M-$100M companies?
Healthcare growth strategy for $10M-$100M companies is fractional product and revenue leadership that owns the handoffs between demand, compliance validation, procurement, integration, and revenue. I install a weekly Revenue Cadence, name owners, and stay until the forecast moves. At a Growth-Stage Healthcare Marketplace, that work delivered more than 60% revenue growth.
Related: healthcare case study, healthcare SaaS growth playbook, healthcare revenue stall playbook, all industries.
60%+
Proof
More than 60% revenue growth. One cadence. Named owners.
At a Growth-Stage Healthcare Marketplace, marketing, product, sales, ops, and credentialing stopped running separate truths. One weekly review. The number moved.
Where does healthcare growth break down?
What I keep seeing in medtech and healthcare IT.
Long sales cycles
Hospital and payer deals run 6 to 18 months. Committees, procurement, budget windows. The deal stalls mid-funnel and nobody owns the push.
Data interoperability
Every EHR or claims hook becomes a one-off build. The roadmap fills with integrations that do not scale, and shipped revenue waits.
Product-sales misalignment
Clinical wants features. Sales sells whatever the RFP asks. No shared stage definitions, no shared forecast. Attribution breaks at the first handoff.
Why generic playbooks fail here
Why do generic healthcare growth playbooks fail?
Slides do not clear procurement. Healthcare buyers need proof, owners, and a path through clinical review and integration. Advice with no owner usually adds a handoff. It does not remove one.
- Pretty deck, thin evidenceProcurement and clinical buyers kill deals that look sharp in slides but have no proof and no owner for the next gate. A consultant leaves a memo. An operator stays on the KPI.
- Deliverables over pipelineBig-firm teams ship the binder. Your weekly pipeline still has no owner when they leave. Install the Revenue Cadence: product and sales in one room, every week, same stage definitions.
- Roadmap ignores riskIntegration and compliance eat capacity. If roadmap choices do not tie to revenue and risk, you end up with a list of custom builds and a forecast that never moves.
The PMGuru approach
How does a fractional healthcare operator work?
I sit in the room and stay until the number moves. I start with the full path to revenue, not one department. Then I fix one handoff at a time until the forecast is honest.
- 01Revenue diagnostic first
Map first touch to renewal. Find where deals stall and who owns the stall.
- 02Unified cadence
One weekly pipeline review. Product and sales in the room. Shared stages, exit criteria, and forecast.
- 03Attribution model
Tie product use, sales touches, and closed revenue. Stop funding motions that do not win.
- 04Pricing and packaging
Tiers that match how healthcare buyers actually approve spend, not how product wants to sell.
- 05Compliance guardrails
Put regulatory checkpoints in the GTM path before ship and before demo. Not after the deal is already late.
FAQ
Healthcare growth strategy FAQ
Direct answers for CEOs, COOs, and PE operating partners evaluating fractional healthcare leadership.
Healthcare insights
Playbooks for stalled revenue, SaaS GTM, and board-level AI calls in healthcare.
B2B Growth
Healthcare SaaS Growth: Revenue Playbook for $10M-$50M
Healthcare SaaS companies at $10M-$50M lose 30-40% of pipeline to compliance friction. Here's the operating playbook to fix it.
Scaling Operations
Healthcare Revenue Stall: Diagnose and Fix Flat Growth at $10M–$100M
Healthcare revenue stalled at $10M–$100M? Diagnose ownership gaps, install KPI tree and weekly cadence, and break the stall. Book a Revenue Strategy Call.
AI & Technology
The Healthcare AI Question Boards Can No Longer Delegate
Healthcare AI is a board mandate now. McKinsey (Apr. 2026): 50% of US healthcare orgs implement gen AI, 80%+ deploy to end users. Link AI to handoffs and P&L. Book a diagnostic.
Next step
Book a 30-minute diagnostic.
I will name the three biggest gaps I see and what to do next. You leave with a clear step either way.